Zachary Roberts
Vermogen: 418 923 $ op 31-05-2026
Vermogen: 418 923 $ op 31-05-2026
Zachary Roberts currently works at Allogene Therapeutics, Inc., as Chief Medical Officer & Executive Vice President from 2023.
Dr. Roberts also formerly worked at Amgen, Inc., as Director-Clinical Medical Research in 2015, Instil Bio, Inc., as Chief Medical Officer from 2020 to 2022, and Kite Pharma, Inc., as Vice President-Clinical Development from 2018 to 2019.
Dr. Roberts received his undergraduate degree from the University of Maryland and doctorate degree from the University of Maryland School of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 193.052 ( 0,06% ) | 418 923 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 03-01-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| INSTIL BIO, INC. | Hoofd Techniek/Wetenschap/O&O | 11-11-2022 |
| KITE PHARMA INC | Hoofd Techniek/Wetenschap/O&O | 01-05-2019 |
| AMGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2015 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland School of Medicine
University of Maryland School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Instil Bio, Inc.
Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau